ArticleJournal of family medicine and primary care2020
Interplay of multimorbidity and polypharmacy on a community dwelling frail elderly cohort in the peri-urban slums of Delhi, India.
Article in Journal of family medicine and primary care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Nationwide insights into frailty: Systematic review and meta-analysis of community-based prevalence studies from India.The Journal of frailty & aging · 2025Pooled it
- Are there socioeconomic inequalities in polypharmacy among older people? A systematic review and meta-analysis.BMC geriatrics · 2023Pooled it
- Cross-sectional observational study on prevalence and pattern of multimorbidity and its impact on geriatric outpatients in a south Indian tertiary hospital.Frontiers in public health · 2026Observational
- Frailty: An overview.Journal of family medicine and primary care · 2026Review
- Medication Use by Older Adults with Frailty: A Scoping Review.Pharmacy (Basel, Switzerland) · 2025Review
- Frailty: a global health challenge in need of local action.BMJ global health · 2024Review
- Predictors of Frailty in the Elderly Population: A Cross-Sectional Study at a Tertiary Care Center.Cureus · 2022Article
- Quality of life of older adults and associated factors in Ghanaian urban slums: a cross-sectional study.BMJ open · 2022Article
- Profile of multimorbidity in outpatients attending public healthcare settings: A descriptive cross-sectional study from Odisha, India.Journal of family medicine and primary care · 2021Article
- Assessment of frailty and outcome of an ethnogeriatric population in periurban slums of Delhi, India - An interventional strategy in a primary health care setting.Journal of family medicine and primary care · 2021Article
- Prevalence of multimorbidity among adults attending primary health care centres in Qatar: A retrospective cross-sectional study.Journal of family medicine and primary care · 2021Article
- Prevalence and Age Structure of Polypharmacy in Poland: Results of the Analysis of the National Real-World Database of 38 Million Citizens.Frontiers in pharmacology · 2021Article
- Overview of multimorbidity research in India: A scoping review.Journal of multimorbidity and comorbidityReview
- Frailty and its Associated Factors Among Rural Community-Dwelling Older Adults: A Cross-Sectional Study.Inquiry : a journal of medical care organization, provision and financingArticle
- Epidemiology and impact of chronic disease multimorbidity in India: a systematic review and meta-analysis.Journal of multimorbidity and comorbidityReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The United Nations Population Fund suggests that the number of elderly persons is expected to grow to 173 million by 2026. The aging phase is further made adverse by conditions such as failty, multimorbidity and polypharmacy.
aimTo assess the status and associates of frailty among elderly (>60 years) residing in a peri-urban slum area in Delhi by using the EDMONSTON Frail scale and evaluate the interplay of multimorbidity (MM) and polypharmacy (PP) on the frail pre-frail spectrum of the community-dwelling elderly cohort.
methodA community study from Dec 2018 till July 2019 with a sample size of 300 participants who were willing and consented to the study. Frailty was assessed and the STOP criteria was used for PP assessment.
resultThere were 76 frail, 51 pre-frail, and 173 non-frail elderly. A higher prevalence (51%) of multimorbidity among the pre-frails and a higher probability (74%) of polypharmacy among the frails were found. Of the total in the frail-prefrail spectrum (127), 29.1% had multimorbidity (MM) and 39.4% had polypharmacy (PP). MM and PP were significantly higher among the old. Factors such as sex, marriage, loneliness, social circle, and education also had a positive bearing on the frailty-prefrailty spectrum. The working group had an increased (86%) probability of PP with statistical significance. Regression analysis depicted significant increased odds of MM and PP among female, illiterate, very old, lone, and single subjects. DISCUSSION AND
conclusionThus, we recommend earlier and timely intervention for the frail-prefrail which can revert their adversities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.